Polypharmacy in the elderly by Veehof, Leonardus Johannes Gerhardus
  
 University of Groningen
Polypharmacy in the elderly
Veehof, Leonardus Johannes Gerhardus
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
1999
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Veehof, L. J. G. (1999). Polypharmacy in the elderly. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
)rugs & Aging 1994;4:449-461"
Lk L, de Boer A, Porsius A' Non-
; by longínrdinal data analysis Pharm
severity of adverse drug reactlons ln
resource for epidemiologic studies:
\'7 -45.
lm-de jong B. Spiegel op de hulsarts'
n de geautomatiseerde huisartspraktijk'
gens de regels' Compliantie van twee
sarts Wet 1998;41 (9) :41 6-9 '
on DP, Comoni HuntleY J' Medicatton
Study.  J Am Ger iatr  Soc.1987"35:4-12'
rive study of drug reporting by general
vice. BMJ lg8'7 ;294(656'7):289 -90'
riliry of drug histories in a specialized
i1) :39-43.
ethods for estimating the occurence of
Eur J Clin Pharmacol 1997;53:7-ll'
rm benzodiazepine treatment' Br J Gen
pines in general practice. Dan Med Bull
Van der Horst FGEM. Interventies in de
[en. Een literanrurstudie. Huisarts Wet
renzodiazepine users in general practlce'
ingsmiddelen in het dagelijks leven'
[Thesis] University Maastricht 1998'
Reduction of polyphaÍmacy by feedback
ndomized, controlled trial of a clinical
rrescribing in elderly outpatients with
Meyboom-de Jong B. Farmacotherapte
ed-back door de aPotheker oP het
,eskd I 994; I 38(3 5't:1'7'7 0-4'
DA. Cuide to good prescribing' World
10 Summary
Introduction
In this thesis the combination of drugs used by elderly people has been
sfudied. The elderly tend to use more drugs than younger age groups.l
Since approximately one-half of the elderly use two or more drugs
concomitantly and one-third use two or more long-term, polypharmacy is a
central concept when considering this population's drug use.
In the various chapters of this thesis the extent and nature of polypharmacy
are studied, also what emerges from the literature about polypharmacy,
which determinants are important in the development of polypharmacy and
fthe scale of problems caused by polypharmacy. Two different research
methods were employed. The first traces Gp records of reported side effects
and the relevant follow-up. The second was an indirect measure searching
for possible "tracers" caused by specific medications. Examples of the latter
would be the development of fluid retention through concomitant use of a
diuretic and an NSAID and the use of gastric agents by patients with
polypharmacy.
A clinical lecture (chapter 2)
A clinical lecture was used to demonstrate how polypharmacy develops in
the elderly. This example shows both polypharmacy's potential to cause
problems in the elderly and the implications for the general practitioner.
Three cases demonstrate that it is not always possible to avoid
polypharmacy, and that reduction is not simply accomplished by lowering
the amount of drugs a patient is taking. Increasing age sometimes leads to
polypharmacy and is linked wirh increase of morbidity. still, the overall
medication of the elderly patient should be critically (re)assessed at times.
specific opportunities to undertake such an (re)assesment would be when
registering a new patient, after hospitalization, in case of deterioration of
health, or with the exacerbation of a specific disease. In these cases, the Gp
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has to rely on thc expcrtise and cogperatiou oí' the pltarmacist. lt is an
advantage that the lattcr is usuitl ly able to look al thc over-all mcdication of
the elclcrly patienl witlt an open mind. Thc GP is thc idcit l persoll to
supcfv ise and coordinatc thc vat ' ious ntcdicat ions o l ' t i lc  ind iv idual  pat iuni
Literature revic\1 (cirapter 3)
A l i tc le turc scarc l i .  focusing on pol l 'pharmacy'  in  c ldcr l l '  pat icnts.  Icvcalcd
(hc lact that thcre is no uuivcrsally accepted deÍ' init it ln Íbr polypharrr-tac\'.
Tiris nrakes thc comparison clÍ '  diÍfèrcnt studics cliff icult.Onc can nrughll '
dil ' tclcntiatc bctween a qualirative ancl a quautitative ciefinit ion. Qualitativc
poly'pharmacy oÍten includes the ltcgatlve aspects of polypharnlacy such as
" too nruch".  " too o1tcn" ,  aud " too lo t tg"  cotubined lv i t l l  t l tc  var ious
prol t lenrs i i  causcs.  Fur ther  rcscarch ( ) l . l  pc l l 'pharmacl 'ca l ls  l i l r  a l t
unanrbiguous dc l in i t ion o1 thc concept .  In  the prcsenl  s tuc l1 ' .  pol ; 'pharnlac l
has bccn dcfincd as lhe usc ttÍ '  two or nrore drugs at ollc t inlc u'ith tltc
crnphasis on mul t ip le drug use over  a long per iod of  t i l l tc .
Thc avcr.agc nutnbcr of drugs used by elderly patients varicd frclm two tci
six. Thc incidcncc ol- polypharntacy rattged fronl 357t, Lo 60(/r,. Ma1or
polvphulmacy,(the use of rnore than l ' ive drugs ccit.tcomitantlyl ocrcurred in
10f l  to  201i  of  cases.  T l ie  vanous studies cat t l lo t  be contpalcd:  th is  ls
causcd b1 thc Í 'act t itat dif lcrcnt trtethttds arc uscd ttt nlcasufe
polvphurnuct , .  Thc populat ious oí '  c ldcr l l '  examined iu t l tc  sepalate studic- t
lure also dií ' Íèrcnt at' id trtt l alrvavs represcntative. In nclrrlv evcr)' stud\.
card iovascular  drugs (especia l ly  d iuret ics) .  psycholept ics.  and aualgesics
werc thc most conrmonly' prescribed drugs. Long-tem drug conlbinations
ofteu involved cardiovascular drugs, anti-diabetics, and asthnra/COPD
drugs. lt \\ 'as impossiblc to discover tirc extent oÍ' polyphamracy's
contr ibut ion to e lder ly  pal icnts 'heal th p lobicms by looking solc ly  at  thc
l i teraturc.
Fol lpharmacl 'should bc nrcasured quant i ta t ivc ly .  ic  t l ie  usc o l  two or  l l lorc
dr-ugs. To makc an1,'valuable qualitativc conclusions or statentcnts. a closet
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Extent of polypharmacy (chapter 4)
Approximately 35% of the elderly population uses two or more drugs
concomitantly, long-term. Major polypharmacy was seen in approximately
5% of the elderly population examined in the present study. A recent
Danish study found similar results, although other studies have revealed
higher percentages.r'2'3'4 Our study's emphasis on chronic polypharmacy
could explain the finding of a low five percent.
While a Danish study has recently shown that three months may be long
enough for such a study, we chose six months.5 We believe a clinically
more relevant picture can be obtained with an extended study period.
Another reason for the low prevalence may be that of some of the drugs,
such as anticoagulants, asthma inhalation drugs, and NSAIDs the exact
duration could not always be measured. Moreover ointments, OTC-drugs,
and homeopathic medication were excluded from the study.
As for polypharmacy, cardiovascular agents (especially diuretics) and
psycholeptics (especially sedativesihypnotics) are predominant. Diuretics are
often prescribed in combination with other drugs. The combination of
digoxin with a diuretic is especially important because of possible
interaction; 2.6% of the elderly population use this combination long-term.
Other clinically relevant combinations are: diuretics with ACE-inhibitors
(4.2% of the elderly population) and diuretics with NSAIDs (1.3% of the
elderly population). Approximately 1.4% of the elderly population are long-
term users of the combination involving a calcium antagonist with digoxin.
The combination of calcium antagonists, verapamil especially, with digoxin
can cause interaction. Our study establishes that prevalences of potentially
interactive, long-term drug combinations were low in number. Our results
were lower than those of Heerdink, who found an overall prevalence of
18% to 19% for patients over 60 years of age.u An explanation for this
difference may lie in the fact that the present srudy focussed on long-term
drug use.
The development of polypharmacy (chapter 5)
The question we put ourselves was how polypharmacy develops over time.
We studied drug use in the elderly longitudinally during a four year period.
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During the course of the four years, polypharmacy siowly iucreases. This
corresponds u i th other  rcscarc l t .6
In 19% of the elderly cohort the long-term drug use increased lrom no or
just one drug(s) at the beginning of the study, to two or more by the end of
the study period. ln less than thrce percent of the elderly, the drug use rose
frorn no or just one drug to tbur or more drugs used simultaneously at the
end o1' t ire study. Drawing a dircct association between deterioratiou of
health and the extent of polypharmacy was not possrble in this study. The
number of diseases pcr patient did not increase significantly with incrcasing
polyphannacy. An increase in the number o[ discases was seel] in the group
oí patlents with the most dramatic increase in polypharmacy. No definit ive
conclusions can be drawn, however, as this is such a small group. The
elderly who showed an increase in polypharmacy over time did not have a
higher avcrage nunbcr of encountcrs with the GP than thc elderly whosc
drug use did nct increase. It is remarkable to note, that in the relatively
small 
-eroup of elderly wlto showed a major increase in polypharmacy. the
portion of house-calls in the total amount of encounters increased relatively
less than in the group with an unchanged drug regime. At the start of the
study tirc porlioll of housc-calls in thc total number of encounters of the
first-mentioned group was already higher than in the other groups. The
higher number of patient-doctor contacts werc l ikely due to a greater
morbidit l, in this group at the beginning of the study.
Especially, elderly who use several drugs simultane ously and elde rly
suÍ'fcring diabetcs, cardiovascular diseases,including irypertensiotr. and
elderly wl.to use drugs without a clear indication, are most l ikely to develop
polypharmacy. This development of polypharmacy is associated with the
occurrence of hypertension and atrial fibrillation and to a lesser degree with
coronary ischemia. The largest increase was associated with congestive
heart failure (CHF) and the use of drugs for which there was no clear
indicat ion.
Problems caused by polypharmacy (chapter 6)
There are important weaknesses Íbr measuring the frequency of adversc
drug rcactions (ADR) i.e.: controlled clinical trials, spontaneous reporting,
prescription cvent monitoring, cohort studies, case control studies, and
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R reports can give only an
indirect estimate of true ADR rates, and bear little relationship to the actual
incidence of ADRs.8 It has been shown that one of the most important
predictors of risk in this regard is the absolute number of drugs.e''o'rr
No correlation was found during our study, between side effects reported by
the GP and the extent of multiple drug use in the elderly. An important
difference between the aforementioned research and ours, however, was that
we studied long-term drug use.
The question we must ask ourselves is whether symptoms caused by the
side effects from and/or interactions between drugs in combination are
recognized by the GP, and whether or not these are adequately registered
by the GP.t2 Since these problems are relatively rare, they may not always
be seen and registered by the GP.r3'r4 The recognition of drug interactions
in the elderly is further complicated by co-morbidity and co-medication,
which is commonly seen in these patients. The incidence of problems
induced by interactions is so low, that research results would only be
significant when large databases are used, containing data from many
general practices.
Our research shows that elderly patients with polypharmacy do not have
more adverse effects than elderly patients who use less than two drugs. The
risk of adverse effects is especially large in elderly with urinary tract
infections, sleeping disorders, coronary heart disease, and asthma/CoPD.
Two clinically relevant combinations of drugs
In chapter four (table 4) a survey is given of the most frequent combinations
of drugs in the elderly. One clinically relevant combination has been further
investigated, i.e. diuretics and NSAIDs. The relationship between
polypharmacy and gastric agents is also examined.
Diuretics and NSAIDs (chapter 7)
The combination of NSAIDs with diuretics was examined because the
elderly suffer from many disease processes which require treatment with
these drugs. Cardiovascular diseases, including hypertension and symptoms
involving the musculoskeletal system are both highly prevalent among the
elderly. Moreover, this combination can lead to interactions. With
concurrent use of diuretics and NSAIDs, the risk of hospitalisation because
1 1 1
oÍ' congestive hearthfailure is twice as high as in elderly who were solely
tak ing d iuret ics. r5
In the present study, we examincd whethcr or not cHF and ankle edema. as
symptons of Í luid retention in eldcrly patients using diuretics and start with
an NSAID, occur more often than in elderly using diuretics who start with
an analgesic or a sedative-hypnotrc. Elderly patients on diuretics who start
using an NSAID do not have a higher incidence of cHF and ankle edema
than comparable patients who start using an airalgesic or a sedative-
hypnotic. Bcing male, suffering hypertension, cHF or ankle edema predict
more oÍien fluid retention than the init iation of either an analsesic or a
sedative-hypnotic.
Polypharmacy and gastric agents (chapter 8)
Arc gastlrc agents mainly prescribed to protect the stomach during multiple
drug use'/ hi l i terature no information could be found on this matter. whcn
multiple drugs are used. one can apprcciate that gastric symptoms such as
stomachache. nausea, and heartburn may occur. Some drugs are known [o
cause objective changes in the stomach wall (i.e.: ulcers caused by
NSAIDs. ascal. prednisolcin).
our research does show a correlation between the use of gastric agents and
polypharnracl'. although thc extent of the polypharmacy only plays a mlnor
roic. lI.-receptor antagonists are thc most commonly prcscribcd gastric
agents. Polypharmacy patients with symptoms and pathology involving the
musculoskeletal system, diabetes and atrial f ibri l lation use more gastric
agents than non polypharmacy patients having the same conditions. To a
Iesser degree also for elderly patients with hypertension, asthma/copD. and
patienst usiug dmgs without a clear indication. Antidepressants and
laxatives are also often associated with the use of gastric agents in patients
who arc already taking ntultrple drugs.
An increasc in drug use is not always associated with an rncreased
likelihood of taking a gastric agent. Sometimes, the higher prevalence of a
diseasc is responsibie for the increased use of gastric agents. Asthma and
coPD is more common in pat.ients who have a moderate degree of
polypharmacy. These patients oflten use prednisolone, which may explain
the increased use of gastric agents by this group. As far as the
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In Chapter 9 the results of the present study are summarized, and the
consequences for the general practitioner, the medical curriculum, and
further research are discussed.
With regard to polypharmacy, there are two major risk groups, which may
be identified; patients with cardiovascular pathology and patients who use
psycholeptics long-term. Elderly patients with cardiovascular pathology
generally use more drugs than other elderly patients. The specialist plays an
important role for these patients. The drugs prescribed are often necessary
for improving the quality and expectancy of life. The GP has an important
coordinating role in these. For improvement of drug compliance and
surveillance of interactions and side effects, cooperation with pharmacist
and specialist should be stimulated, for example by FTTO.
Elderly patients using psycholeptics (mainly sedatives-hypnotics) long-term
are a second group, which is at risk of developing polypharmacy. Often, the
indication for prescribing is unclear or no longer present. There is room for
intervention in this area, especially when the goal is discontinuing the
medication. Experience has shown that discontinuing sedatives-hypnotics is
difficult. The key therefore lies in the prevention of use of sedatives-
hypnotics in the first place. This may be accomplished by presenting the
patient with alternate treatment options. During their medical studies, young
doctors should be taught more about discontinuing specific drugs. with this,
the expertise of the pharmacist can be used more than previously was
possible. karning to stop prescribing a drug should be emphasized in
medical schools, the same way that learning to prescribe drugs is learned.
Research investigating a reduction in unnecessary polypharmacy involving
the discontinuance of specific drugs is necessary, such research should
examine and measure the effect on the patient, his/her better health, quality
of life, and a lesser number of complications. The fact that polypharmacy
lends itself to examination within general practice means that the sources of
polypharmacy (especially when looking at causes and rationality) can be
readily researched. such research presents us with the possibility of a
higher level of cooperation between the Gp, the specialist, and the
pharmacist.
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